Annandale Capital’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-25
| Closed | -$4K | – | 139 |
|
|
2022
Q4 | $4K | Buy |
+25
| New | +$4K | ﹤0.01% | 134 |
|
|
2022
Q3 | – | Sell |
-44
| Closed | -$38K | – | 155 |
|
|
2022
Q2 | $38K | Hold |
44
| – | – | 0.02% | 126 |
|
|
2022
Q1 | $110K | Hold |
44
| – | – | 0.04% | 111 |
|
|
2021
Q4 | $112K | Hold |
44
| – | – | 0.05% | 112 |
|
|
2021
Q3 | $199K | Hold |
44
| – | – | 0.12% | 80 |
|
|
2021
Q2 | $300K | Hold |
44
| – | – | 0.18% | 69 |
|
|
2021
Q1 | $319K | Hold |
44
| – | – | 0.23% | 54 |
|
|
2020
Q4 | $352K | Buy |
+44
| New | +$352K | 0.29% | 40 |
|